INSM earnings date and last-quarter result: next report 2026-08-06, last quarter beat, P/E -18.55. Updated 2026-07-23.
Insmed (INSM) Research Hub
Insmed (INSM) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 93.33 USD (-0.06%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -18.55, market cap 23.01B. This hub links to the full technical, earnings and options research available for INSM.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 93.33 USD (-0.06%) |
| 52-week range | 92.625 USD – 137.7 USD |
| Trend regime | Range |
| 14-day RSI | 19.9 (Oversold) |
| Trailing P/E | -18.55 |
| Market cap | 23.01B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-06 |
Available research for INSM
Covered Call on INSM: how it works, illustrative setup around the real 93.33 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on INSM: how it works, illustrative setup around the real 93.33 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on INSM: how it works, illustrative setup around the real 93.33 USD price, max profit/loss, breakeven and when to use it. Educational.
INSM technical analysis: range, last 93.33 USD, RSI 19.9, 52w range 92.625 USD–137.7 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is INSM in?
Insmed (INSM) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is INSM in an uptrend or downtrend?
As of 2026-10-26, INSM is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is INSM's trailing P/E ratio?
INSM's trailing P/E is -18.55, with a market cap of 23.01B. See the earnings research page for full valuation detail.
When does INSM next report earnings?
INSM is next scheduled to report earnings on 2026-08-06.